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Abstract: The prevalence of multidrug-resistant Staphylococcus aureus has increased during the last few years in 
healthcare facilities, and methicillin-resistant Staphylococcus (MRSA) in particular has emerged as a serious 
nosocomial pathogen because it is difficult to destroy and treat. Therefore this study was carried on to find out the 
frequency of MRSA among S. aureus isolates as well as to study their susceptibility profile. In this study, 43 strains 
of S. aureus were recovered from different departments at Sebha medical center and their antibiotic resistance 
profile was studied using Kirby Bauer disc diffusion method. Out of all 43 isolates, 16% were detected as MRSA 
using cefoxitin disk test. The strains that are resistant to erythromycin were further tested for inducible clindamycin 
resistance (ICR) using D-test. In this study, two strains showed ICR phenotype. While all isolates were 100% 
sensitive to vancomycin, the majority of isolates were resistant to ß-lactam group antibiotics. We observed that 14% 
of all isolates were resistant to ß-lactamase inhibitor. The response of S. aureus isolates to other antibiotics e.g. 
quinolone, aminoglycosides, tetracycline and macrolides was variable. In our study, it seemed to be vancomycin is 
the only antibiotic that still keeping its potency and it can be used for treatment of infections caused by multidrug-
resistant MRSA. 
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1. Introduction 
 
Staphylococcus aureus is an opportunistic 
pathogen, which have become one of the most hospital-
acquired pathogens [1, 2]. S. aureus can be found as 
normal flora in healthy humans, but on the same time, it 
can be a leading cause to many diseases including skin 
and tissue infection or in worse cases septicemia and 
infective endocarditis [3]. S. aureus in general and 
methicillin-resistant strains (MRSA) in particular are of 
clinical significance because they confer resistance to 
different groups of antibiotics that render the treatment 
more difficult. In fact, the MRSA is not only considered 
as nosocomial pathogen but it has also been isolated 
from community settings [4]. MRSA was first reported 
in 1961 shortly after introduction of methicillin in the 
health facilitates [5] and thereafter became one of the 
most frequently isolated organisms worldwide [6, 7].  
S. aureus has ability to evolve its lifestyle and 
become a successful opportunistic pathogen through 
acquiring mobile genetic elements that code for 
virulence and antimicrobial resistance from other 
bacteria by horizontal gene transfer [8,9]. 
The resistance of S. aureus to methicillin and to all 
β-lactam antibiotics is mediated by mecA gene that 
codes for modified penicillin-binding protein (PBP2a), 
this gene is found on the staphylococcal cassette 
chromosome mec (SCCmec) [10, 11, 12, 13]. 
The resistance of S. aureus and mainly MRSA 
against antimicrobial agents has recently become wider 
to involve quinolones, aminoglycosides, and macrolides 
[12, 14, 15, 16]. The macrolides group (e.g. 
erythromycin) was an alternative drug for penicillin-
resistant for a long time, but its usage has been limited 
during the last years because of the development of 
macrolides resistance [17]. Moreover, resistance to 
lincosamide (e.g. clindamycin), which is the drug of 
choice to treat skin and soft tissues infection caused by 
S. aureus, has also been detected [18, 19]. 
Although glycopeptides, notable vancomycin was 
considered a cornerstone for treating the MRSA but 
resistance to this drug has unfortunately also developed 
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[20]. The presence of multiple resistant genes carried 
by MRSA strains considered as one of the risk factors 
that participate in its spread.  
However, MRSA among health-care and 
community settings and their antibiotics resistance 
pattern has extensively been studied in Libya [21, 22, 
23,24, 25, 26, 27, 28, 29, 30, 31], where they suggested 
that healthcare workers (HCW) could be a source of 
MRSA dissemination between the medical staff and 
directly to the patients. However, The HCWs may 
further spread this organism (MRSA) to their household 
members and thereby they increase frequency of 
community-acquired MRSA infection making the 
problem even worse [32]. It has also been found that 
the rate of MRSA has increased in Libyan hospitals 
during the last decades in patients with burn and 
infected surgical wound [24, 25].  Zorgani and his team 
have also isolated inducible clindamycin resistant 
Staphylococci from burn patients in Tripoli, Libya [33].  
Despite all these studies that have been undertaken 
in Libya, yet very little is known about the prevalence 
of MRSA in south of Libya especially Sebha, and this 
project is considered as the first study carried in this 
area so far. Therefore, we in present project focused on 
the prevalence of MRSA among isolates collected from 
hospitalized patients as well as people attended 
outpatient department over a period of two years 
(January 2015-January 2017). The antimicrobial 
susceptibility pattern against different antibiotics was 
also studied in this project. 
 
2. Material and Methods 
 
2.1 Clinical Isolates 
Between January 2015 to January 2017, 43 S. 
aureus isolates were collected from wound, pus, 
oropharyngeal, and screen swabs (nasal and neonate 
incubators). 29 strains of S. aureus were isolated from 
different hospitalized patients, while 9 isolates from 
patients attended outpatient department. The remaining 
was collected from neonatal incubators (2) and medical 
staff (3). After identification, all strains were given MA 
number and stored at -700C in our laboratory at Sebha 
medical center for further study. The details on each 
strain are available in Table 1. This study was done in 
Microbiology department, Sebha medical center. The 
clinical samples were grown on 5% sheep blood agar 
medium (Oxoid, England) and incubated overnight at 
370C. S. aureus isolates were identified by (Gram stain, 
catalase test) and confirmed by cultured on Mannitol 
salt agar (Oxoid, England) and DNase plates (Oxoid, 
England). 
 
2.2 Antimicrobial susceptibility testing 
The confirmed S. aureus isolates were screened for 
their susceptibility to different antibiotics according to 
CLSI [34] guidelines using Kirby Bauer disc diffusion 
method. A 0.5 McFarland standard suspension for each 
strain was prepared and used for all susceptibility tests. 
The bacterial suspension was performed on Mueller-
Hinton agar (MHA) plate (Oxoid, England). The 
following antibiotics were used, Penicillin G (5μg), 
Ampicillin (10μg), Erythromycin (30mg), Vancomycin 
(30mg), Gentamicin (30μg), Ciprofloxacin (5μg), 
Ceftriaxone (30μg), Imipenem (10μg), Amoxicillin 
(25μg), Tetracycline (30μg), and Amoxicillin-
clavulanic acid (30μg) (Bioanalyse, Ankara/ Turkey).  
The plates then were incubated for overnight at 350C. 
 
Table 1. Distribution of S. aureus isolates by departments used in 
this study. 
 
Strain number Department Source 
MA40 Neonate Skin swab 
MA52 Neonate Rectal swab 
MA58 Female surgical ward Diabetic foot 
MA69 Female surgical ward Wound 
MA70 Female surgical ward Thigh abscess 
MA81 Male surgical ward Urinary catheter 
MA101 Female surgical ward Abscess 
MA102 Female surgical ward Wound 
MA116 Male surgical ward Leg abscess 
MA142 Pediatric Chest aspiration 
MA151 Female surgical ward Abscess 
MA152 Male surgical ward Wound 
MA158 Male surgical ward Diabetic foot 
MA161 Male surgical ward Abscess 
MA162 Female surgical ward Abscess 
MA163 Female surgical ward Abscess 
MA164 Male surgical ward Diabetic foot 
MA172 Male surgical ward Diabetic foot 
MA173 Female surgical ward Inguinal abscess 
MA174 Female surgical ward Breast abscess 
MA180 Neonate Incubator 
MA181 Neonate Incubator 
MA183 Male surgical ward Cellulitis 
MA191 Neonate Nasal swab 
MA197 Female surgical ward Axillary abscess 
MA214 Ophthalmology Swab 
MA218 Neonate Oropharyngeal swab 
MA220 Neonate Nasal swab 
MA221 Neonate Nasal swab 
MA238 Neonate Oropharyngeal swab 
MA242 Male surgical ward Wound 
MA251 Male surgical ward Postoperative wound 
MA256 Male surgical ward Abdominal abscess 
MA258 Neonate Oropharyngeal swab 
MA263 Female surgical ward Chest wall abscess 
MA4 Outpatient department Sputum 
MA155 Outpatient department Burn 
MA160 Outpatient department Abscess 
MA171 Outpatient department Abscess 
MA85 Outpatient department Genital abscess 
MA98 Outpatient department Nasal abscess 
MA113 Outpatient department Ear swab 
MA153 Outpatient department Abscess 
 
2.3 Detection of MRSA by Cefoxitin disk 
Resistance of S. aureus isolates to methicillin was 
determined by using a 30μg Cefoxitin disk. The plates 
were incubated at 350C for 18-24h. The results obtained 
from this experiment than were interpreted according to 
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Clinical and Laboratory Standards Institute (CLSI) 
guidelines. 
 
2.4 Inducible Clindamycin resistance screen test (D- 
shape test) 
All S. aureus isolates that found to be resistant to 
erythromycin were further screened for Inducible 
clindamycin resistance. Clindamycin (2μg) and 
erythromycin (15μg) disks (Bioanalyse, Ankara/ 
Turkey) were placed at a distance of 15mm (edge to 
edge) from each other. The plates were incubated at 
350C for 18-24h. Appearance of D-shape zone in 
between the two disks and toward the clindamycin is 
considered positive for inducible clindamycin 
resistance. 
 
3.  Results and discussion 
 
This study represents the prevalence of MRSA 
throughout different departments at Sebha Medical 
center, which is considered as the central hospital 
covering almost the majority of south Libya. We 
analyzed forty-three S. aureus strains collected from 
different department at Sebha medical center, Libya. 
Further, 43 isolates were subdivided into two groups, 
34 are hospital isolates (Inpatient (IP) and screen swabs) 
and 9 are from outpatient department (OP) (details in 
Table 1). All 43 isolates were subjected to antimicrobial 
susceptibility test. Initially, we could see that out of 43 
strains, 84% and 88% were resistant to penicillin and 
ampicillin respectively (Fig. 1, Table 2, Fig. 2). This 
study showed that 14% of all isolates (IP & OP) are 
resistant to β-lactamase inhibitor (Augmentin). Among 
all isolates, 19% were resistant to ceftriaxone, 30% 
were resistant to tetracycline, 12% were resistant to 
gentamicin, 7% are resistant to ciprofloxacin, and 2% 
resistant to imipenem. Out of 43 isolates, seven isolates 
(16%) were confirmed MRSA positive using cefoxitin 
30μg (Table 2). Four MRSA isolates were isolated from 
surgical departments and 2 from neonate while one 
strain was from outpatient department (OP-MRSA) 
(Table 3/Fig. 3). Among the whole collection, as noted 
from Table 3, the highest number of MRSA was from 
surgical departments (9%) followed by neonate (5%) 
whereas 2% was isolated from outpatients. Focusing on 
MRSA susceptibility pattern, we found all MRSA 
isolates resistant to ceftriaxone, 71% resistant to 
gentamicin, 43% resistant to ciprofloxacin, 43% 
resistant to erythromycin, and all of MRSA strains 
sensitive to tetracycline. However, all MRSA are 
sensitive to imipenem except MA 238 (isolated from 
neonate), showed resistance phenotype. MA238 was 
only sensitive to tetracycline and vancomycin. Luckily, 
our study did not show any resistance to vancomycin 
and all 43 isolates (MRSA and MSSA) were 100% 
sensitive. The strains, that showed resistance to 
erythromycin (19%), were further studied for inducible 
Clindamycin test (D-shape test) (Table 4/Fig. 4A&B). 
Interpretation of the result was done according to 
Fiebelkorn [35], Strains resistant to both erythromycin 
and clindamycin were considered to have constitutive 
clindamycin resistance (cMLSB). But when the Strains 
showed flattening of the circular zone of inhibition 
toward clindamycin it is considered inducible 
clindamycin resistance (iMLSB). The susceptible 
strains with circular zones around the clindamycin were 
considered to be clindamycin susceptible [35]. So, we 
observed two strains, MA162 (IP-MSSA) and MA4 
(OP-MSSA), were iMLSB, where they exhibited 
resistance to erythromycin and sensitive to Clindamycin 
with flattening or blunting of the inhibition zone toward 
clindamycin (D-shape positive) (Table 4/Fig. 4A). Only 
MA238 (IP-MRSA) was resistant to both erythromycin 
and clindamycin, which considered as cMLSB (Table 
4/Fig. 4B) with no inhibition zone around them. Other 
erythromycin-resistant strains IP-MRSA (MA251, 
MA258) and IP-MSSA (MA81, MA180, MA181) were 
sensitive to clindamycin (Table 4) and according to 
Fiebelkorn, they considered to be MS. 
 
 
 
Fig. 1. Antibiotic Resistance profile of S. aureus isolates to different commonly used antibiotics. 
0
10
20
30
40
50
36 38 37
6 7 8 13
5
3
0 1
8
7 5 6
37 36 35
30
38 39 43 42
34
Resistance Sensetive
MRSA: A real threat to public health                         Ahmad et al 
J Adv Lab Res Biol (E-ISSN: 0976-7614) - Volume 9│Issue 1│2018  Page | 4 
 
 
Fig. 2. Antibiotic resistance rate of S. aureus isolates. 
 
Table 2. Susceptibility pattern of all 43 S. aureus isolates to 
different groups of antibiotic. 
 
Antibiotics Sensitive Intermediate Resistance 
Resistance 
rate 
Penicillin 7  36 84% 
Ampicillin 5  38 88% 
Amoxicillin 6  37 86% 
Amoxicillin-clavulanate 37  6 14% 
Cefoxitin 36  7 16% 
Erythromycin 35  8 19% 
Tetracycline 30  13 30% 
Gentamicin 38  5 12% 
Ciprofloxacin 39 1 3 7% 
Vancomycin 43  0 0% 
Imipenem 42  1 2% 
Ceftriaxone 34 1 8 19% 
 
Table 3. Distribution of MRSA according to hospital departments. 
 
MRSA/ MSSA/ Department Number of MRSA/MSSA Rate (%) 
MRSA 
Surgical wards (MA69, 
MA263, MA172, MA251) 
4/43 9% 
Neonate 
(MA238, MA258) 
2/43 5% 
Outpatient 
(MA171) 
1/43 2% 
MSSA (All departments) 36/43 84% 
 
 
 
 
Fig. 3. Frequency of MRSA strains by departments. 
 
The current study was conducted at Sebha medical 
center, which located at south of Libya and represents 
the biggest hospital in this area. The healthcare workers 
with improper hand hygiene are reported as a source of 
transmission of hospital-acquired pathogens among the 
hospitalized patients. In addition, the migration has also 
been reported as one of the risk factors of multidrug-
resistant organisms transmission. Heudorf and his 
group on 2016 [36] have found that 9.8% of the 
refugees in Germany were colonized with MRSA. 
Further, Ravensbergen has reported a similar result on 
2017 [37], where he found that 10% of Asylum seekers 
to Netherlands were MRSA positive compared to 
general patient population rate, which was 1.3%. 
 
 
 
Fig. 4A. Inducible macrolide-lincosamide-streptogramin B (D-test positive). B: constitutive macrolide-lincosamide-streptogramin B resistance. 
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In Libya, especially after revolution 2011, 
overflow of immigrants importing multidrug-resistant 
organism, war-injured patients with lack of health 
services, suboptimal infection control and improper 
antibiotic prescription all might have contributed to 
prevalence of MRSA and other multidrug-resistant 
pathogens. After Revolution February 2011, 51 Libyan 
injured soldiers were transferred to major incident 
hospital in Utrecht, Netherland. A 10% was detected as 
MRSA among all 51 injured people, and MDR was 
found in 59% [38]. 
Based on studies conducted in Libya, the number 
of MRSA has increased during the last years 
particularly in surgical ward and burn patients [24, 21].  
Furthermore, Zorgani, 2009 [21] has reported that 18% 
of the S. aureus isolates collected from healthcare 
workers at six different hospitals were MRSA. Our data 
showed the number of MRSA isolated from 
hospitalized patients is higher than the isolates from 
outpatient, 18% and 11% respectively. With respect to 
the sample size, this result is similar to the one found by 
Wareg and his team on 2014 [27], when around 511 
strains of S. aureus were collected between October 
2009 and November 2010. Interestingly, similar to 
results obtained by Buzaid, 2011 [24], we found that 
the majority of MRSAs are from surgical department. 
In this study, we could see that a few strains were 
sensitive to β-lactam group and this is because they do 
not produce β-lactamase, while 37 out of 43 were 
sensitive to β-lactamase inhibitors 
(Amoxicillin/Clavulanate). The resistance to β-
lactamase inhibitors (14%) in this study was mainly by 
MRSA. This finding, which is not surprising, has been 
reported many years ago by Brumfitt [39] and has been 
confirmed by other studies [40]. Our study revealed that 
majority of MRSA was resistant to β-lactams 
(Penicillin, Ampicillin, and Ceftriaxone), β-lactamase 
inhibitor (Amoxicillin/Clavulanate), aminoglycoside 
and quinolones (Ciprofloxacin). This observation is in 
agreement with the same finding reported by other 
researchers [41, 42, 43, 44, 24]. 
On the other hand, some published studies reported 
that 0% resistance of MRSA to ciprofloxacin and 5% to 
gentamicin [27], but ours showed 43% of MRSA were 
resistant to ciprofloxacin and 71% to gentamicin. 
Furthermore, we noticed that this resistance to 
ciprofloxacin and gentamicin is only exhibited by 
MRSA but not MSSA strains. For this reason, 
quinolones, which have previously been used for 
MRSA treatment [45, 46], are not recommended 
anymore and this finding is supported by other studies 
[47]. 
Luckily, between all MRSA and MSSA isolates 
enrolled in this study, only single strain was resistant to 
imipenem, MA238. Such a very low resistance to 
imipenem suggesting it can still be used for treatment 
of MRSA. 
For many years, vancomycin was considered as the 
golden antimicrobial agent against multidrug-resistant 
MRSA, but regrettably, has also developed resistance. 
In contrast, to study undertaken in the same area on 
2015, Sebha, where they found that 90.5% of S. aureus 
were resistant to vancomycin [48], all our strains 
showed the opposite and were 100% sensitive to 
vancomycin. This observation is consistent with other 
study [43]. Contrary, some studies had reported 
resistance of MRSA to vancomycin [49, 50, 51].  
However, the emergence of β-lactams resistant S. 
aureus strains in the last few years have led to 
introducing other antibiotics to eradicate S. aureus 
infections, for instance, macrolide, lincosamide and 
streptogramin B (MLSB) [35]. Nevertheless, resistance 
to macrolides may also be acquired through either 
active efflux encoded by msrA or modification of 
enzymes encoded by ermA or ermC genes (Macrolide, 
Lincosamide and Streptogramin B resistance (MLSB)) 
[52]. In this study, out of 43 isolates, 8 (19%) were 
resistant to erythromycin. Among 8 erythromycin-
resistant strains, 2 (5%) detected positive for inducible 
clindamycin resistance (ICR) and gave D shape. The 
false clindamycin susceptibility result may mislead the 
clinicians to use this antibiotic in treatment of 
Staphylococcus infections. This misinterpretation can 
happen if the isolates were not tested for ICR. 
Therefore, to avoid the failure with clindamycin therapy, 
the microbiologist should routinely perform this simple 
test. 
In relation to MRSA and MSSA, our study did not 
detect Inducible clindamycin resistance among MRSA 
rather they were predominant in methicillin-susceptible 
S. aureus isolates, while the constitutive phenotype was 
observed in MRSA only. This finding is in line with 
other studies were they also reported higher rate of ICR 
in MSSA compared to MRSA [53,54,2]. In general and 
regardless MRSA or MSSA, Our data showed the rate 
inducible clindamycin resistance is higher than 
constitutive clindamycin resistance and a similar 
observation has also been reported by Ajantha [55]. 
Conversely, Fiebelkorn [35] in reported higher number 
of Constitutive resistance compared to inducible 
resistance and Nikam has also reported a similar result 
[56]. 
Thus, according to these results with prevalence of 
MDR, we have only few options for treatment of 
MRSA detected in this study. The reason behind this 
fast spread of multidrug-resistant organisms perhaps is 
due to self-medication and improper use of commonly 
prescribed antibiotic. The worldwide prevalence of 
multidrug resistance among MRSA strains and other 
hospital-acquired pathogens has become of critical 
concern and consider as a major public health problem.  
Our study is not surveillance but rather it highlights 
the main problem in our hospital and this progressing 
nosocomial infections problem will increase the 
morbidity if not the mortality rate. 
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4.   Conclusion 
 
Apparently, S. aureus has remarkable ability to 
acquire multiple antibiotic resistance, and a new 
implementation for effective management against 
multidrug-resistant organism must urgently be proposed. 
Further, Hospital infection control and prevention with 
proper education to minimize the spread of MRSA 
should be taken into consideration. Therefore, 
Healthcare worker and patients before admission must 
routinely be screened for MRSA and other nosocomial 
pathogens. 
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